表紙
市場調查報告書

生物製劑:化學藥品供應商的市場機會

Biologics: Market Opportunities for Chemical Suppliers

出版商 Kline & Company, Inc. 商品編碼 766997
出版日期 內容資訊 英文
商品交期: 最快1-2個工作天內
價格
如有價格方面的疑問請按下「詢問」鍵來信查詢
生物製劑:化學藥品供應商的市場機會 Biologics: Market Opportunities for Chemical Suppliers
出版日期: 2019年08月31日內容資訊: 英文
簡介

目前製藥產業見證了全球規模的生物製劑快速普及。已經發現能夠透過更高安全性和效能的生物製劑,治療主要的慢性病和複合疾病,近年產品核准比率也較傳統藥物更高。然而,生物製劑開發和配方帶來了更多挑戰,如高額的研發投資、更長的審核時間、更嚴格的製造程序、以及為了通過藥物監管的困難作業。儘管存在這些課題,藥物開發PIPELINE中的生物製劑種類增加,因此瞭解持續進化的賦形劑作用至關重要。賦形劑不僅是完成的生物製劑投藥時的關鍵成分,在生物製劑本身開發和製造上也扮演了重要角色用,因此選擇和使用適切的賦形劑,對於生物製劑而言相較於小分子藥劑更具重要意義。

本報告分析從生物程序到配方等,於價值鏈快速展現存在感的生物醫藥品市場機會。報告內的生物製劑是指基因重組治療藥物、血漿蛋白質、疫苗等。

本報告闡明以下關鍵關鍵問題:

  • 包含於生物製劑價值鏈中的生物程序重要原料和賦形劑
  • 目前消費情況
  • 活躍於市場的供應商及其產品
  • 價值鏈結構
  • 市場中的產品競爭和獲好評的產品
  • 和生物醫藥品有關的化學藥品平均價格
  • 2023年前的化學藥品消費發展

目次:

簡介

  • 生物醫藥品產業概況
  • 生物醫藥品概述
  • 生物醫藥品類型
  • 生物醫藥品主要企業
  • 生物製劑配方商業案例

生物程序技術

  • 概要
  • 趨勢和展望

生物程序原料

  • 市場規模
  • 等級和價格
  • 各家供應商情況
  • 未來展望

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: Y861

The pharmaceutical industry is witnessing a surge of biologics globally. With higher safety and efficacy, biologic drugs have been found to treat major chronic and complex diseases. In recent years, biologic drugs have enjoyed better approval rate than traditional drugs. However, the development and formulation of biologics bring greater challenges, such as higher R&D investment, longer approval times, a more stringent manufacturing process, and difficult regulatory pathways. With the drug pipeline being increasingly populated with biologics, it is crucial to understand the evolving role of excipients. The selection and use of the right excipients are even more critical for biologics than for small molecule drugs, because excipients are not only key components of the finished biologic drug dosage but also play an important role in the development and manufacturing of the biologic drug itself. Kline aims to provide a comprehensive assessment of excipients in biologics through its new study.

This Report Will Help Subscribers Answer Key Questions Such As:

  • What are the key bio processing ingredients and excipients involved in the biologics value chain?
  • What is their current consumption?
  • Which suppliers are active in the market, and which products are they supplying?
  • How is the value chain structured?
  • Is inter-product competition occurring in the market, and what products are favored?
  • What are the average prices of chemicals related to biopharmaceuticals?
  • How will the consumption of these products evolve by 2023?

Scope & Benefits

‘Biologics: Market Opportunities for Chemicals Suppliers’ comes as a comprehensive report analyzing market opportunities created by the rapid emergence of biopharmaceutical products throughout their entire value chain, from bioprocessing to formulation (Table 1 & 2) In this study, biologics is referring to recombinant therapeutics, plasma proteins, and vaccines.

This report will assist chemical suppliers in understanding the entire biologics value chain and identifying business opportunities within this key growth area. It will also serve as an invaluable tool in the strategic planning process. This program provides subscribers with a report allowing them to:

  • Develop business strategies by understanding the trends that are driving the consumption of chemicals related to biopharmaceutical processing and formulation globally
  • Develop market-entry and market expansion strategies
  • Identify key market participants at various level of the value chain
  • Capitalize by identifying specific chemicals or categories poised for strong growth

Regional Coverage: Global.

Table of Contents*

Introduction

  • Introduction to biopharmaceutical industry
  • Overview of biologic pharmaceuticals
  • Types of biologic pharmaceuticals
  • Major biopharmaceutical companies
  • Commercial examples of biologic formulations

Bioprocessing techniques

  • Overview
  • Trends and Outlook

Ingredients for Bioprocessing

  • Market size
  • Grades and prices
  • Supplier landscape
  • Outlook

* Subject to charter subscriber input.